Yüklüyor......
The Future of Interleukin-2: Enhancing Therapeutic Anticancer Vaccines
PURPOSE: The purpose of our efforts is to trigger the immune destruction .of established cancer. Interleukin (IL)-2 can mediate the regression of tumors in patients with melanoma and renal cell carcinoma. In animal models, the antitumor effects of IL-2 are mediated by T lymphocytes. Stimulation with...
Kaydedildi:
| Asıl Yazarlar: | , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2000
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2538796/ https://ncbi.nlm.nih.gov/pubmed/10685664 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|